Cardinal Health (Cardinal Health) EBIT

: $1,194 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

Cardinal Health's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $498 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $1,194 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cardinal Health's annualized ROC % for the quarter that ended in Dec. 2023 was 14.51%. Cardinal Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 81.52%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cardinal Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.56%.

Cardinal Health EBIT Historical Data

The historical data trend for Cardinal Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardinal Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT

2,045.00

-3,534.00

503.00

-620.00

731.00

Cardinal Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT																-112.00	572.00	136.00	-12.00	498.00

Competitive Comparison

For the Medical Distribution subindustry, Cardinal Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardinal Health EV-to-EBIT Distribution

For the Medical Distribution industry and Healthcare sector, Cardinal Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cardinal Health's EV-to-EBIT falls into.

Cardinal Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,194 Mil.

Cardinal Health (NYSE:CAH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cardinal Health's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	2000 * ( 1 - 27.76% )	/	( (9810	+	10103)	/ 2 )
=	1444.8	/	9956.5
=	14.51 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	43710	-	34277	-	( 3854	-	max(0, 35065	-	34688	+	3854	))
=	9810

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	46573	-	37098	-	( 4591	-	max(0, 38286	-	37658	+	4591	))
=	10103

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Cardinal Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	1992	/	( ( (2441 + max(-3443, 0))	+	(2446 + max(-4031, 0)) )	/	2 )
=	1992	/	( ( 2441	+	2446 )	/	2 )
=	1992	/	2443.5
=	81.52 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(11265	+	16987	+	2582)	-	(34277	+	0	+	0)
=	-3443

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(11788	+	18451	+	2828)	-	(37098	+	0	+	0)
=	-4031

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cardinal Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	1194	/	26165.244
	=	4.56 %

Cardinal Health EBIT Related Terms

Thank you for viewing the detailed overview of Cardinal Health's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardinal Health (Cardinal Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cardinal Health Inc (NYSE:CAH) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

CAH:Mexico CLH:Germany CLH:Germany C1AH34:Brazil CAH:Argentina

Address

7000 Cardinal Place, Dublin, OH, USA, 43017

Website

https://www.cardinalhealth.com

Cardinal Health is one of three leading pharmaceutical wholesalers in the U.S., engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Executives

Deborah Weitzman	officer: CEO, Pharmaceutical Segment	600 WEST 22ND STREET, SUITE 300, OAK BROOK IL 60523
Mary C. Scherer	officer: Chief Accounting Officer	6026 LUDWIG STREET, POWELL OH 43065
Ola M Snow	officer: Chief Human Resources Officer	7000 CARDINAL PLACE, DUBLIN OH 43017
Stephen M Mason	officer: CEO, Medical Segment	7000 CARDINAL PLACE, DUBLIN OH 43017
Jessica L Mayer	officer: Chief Legal/Compliance Officer	7000 CARDINAL PLACE, DUBLIN OH 43017
Michelle D. Greene	officer: Chief Information Officer	1141 N. OLD WORLD 3RD STREET, UNIT # 2414, MILWAUKEE WI 53203
Aaron E Alt	officer: Chief Financial Officer	3001 COLORADO BLVD., DENTON TX 76210
Michelle Brennan	director	1855 S. GRANT STREET, SAN MATEO CA 94402
Sujatha Chandrasekaran	director	77 HOT METAL STREET, PITTSBURGH PA 15203
Christine Mundkur	director
Steven Barg	director	ELLIOTT MANAGEMENT CORPORATION, 40 WEST 57TH STREET, NEW YORK NY 10019
Patricia M English	officer: Chief Accounting Officer	7000 CARDINAL PLACE, DUBLIN OH 43017
Sheri H. Edison	director	1069 STATE ROUTE 46 EAST, BATESVILLE IN 47006
Jason M. Hollar	officer: Chief Financial Officer	3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
John H Weiland	director	C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974